In publicly available genomewide gene expression data, MTSS1 was expressed at higher levels in AML patients with favorable risk according to cytogenetic or European LeukemiaNet classifications than in those with intermediate or poor risk. The gene discussed is MTSS1; the disease is acute myeloid leukemia.